Core Laboratories Inc. Form 8-K Summary
Business Context and Reporting Period
Core Laboratories Inc. (NYSE: CLB) filed a Current Report on Form 8-K on July 24, 2024. The filing serves to disclose the company's financial results for the second quarter of 2024 and the declaration of a quarterly cash dividend.
Key Financial Metrics and Dividend Declaration
The filing references a press release (Exhibit 99.1) containing the detailed financial results for the second quarter of 2024. The 8-K text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
- Dividend Declaration: The Board of Directors declared a quarterly cash dividend of $0.01 per share of common stock.
- Record Date: August 5, 2024.
- Payment Date: August 26, 2024.
Material Changes and Prior Period Comparison
The filing text does not provide specific financial figures or percentage changes comparing the second quarter of 2024 to prior periods. Investors must refer to the attached press release (Exhibit 99.1) for detailed operational results and year-over-year comparisons.
Guidance, Outlook, and Risks
This specific 8-K filing does not contain updated forward-looking guidance, management commentary on future outlook, or a discussion of risks and contingencies beyond the standard regulatory disclosures. The primary purpose of this report is the timely disclosure of Q2 results and the dividend announcement.
Key Facts for Investor Verification
- Verify the full text of the Q2 2024 press release (Exhibit 99.1) for specific revenue, earnings, and cash flow figures.
- Confirm the dividend payment schedule: Record date of August 5, 2024, and payment date of August 26, 2024.
- Note that the information in the press release is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.